Following weeks of mass purges of employees across federal agencies led by Trump officials and Elon Musk‘s so-called ...

The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine ...

The new offers were specific to the will of each agency and not dictated by the Office of Personnel Management, according to ...

Already reeling from years of market chaos, the announced departure of CBER chief Peter Marks sent a ripple across biopharma ...

It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies,” Dr Marks wrote.

FDA's tobacco chief Brian King removed amid sweeping cuts, reshaping tobacco regulation and public health oversight ...

He's ventured far outside of his swim lane,' Cantor Fitzgerald analysts say. 'It's time to take him out of the pool.' Two Wall Street analysts on Monday called on the Trump administration to ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Top FDA official’s exit sends ripples ...

Two Wall Street analysts on Monday called on the Trump administration to "re-evaluate" Robert F. Kennedy Jr.'s role as the secretary of the Department of Health and Human Services, saying his ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...